Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Net Income: 2020-2024

Historic Net Income for Janux Therapeutics (JANX) over the last 5 years, with Dec 2024 value amounting to -$69.0 million.

  • Janux Therapeutics' Net Income rose 13.35% to -$24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.9 million, marking a year-over-year decrease of 68.32%. This contributed to the annual value of -$69.0 million for FY2024, which is 18.36% down from last year.
  • Per Janux Therapeutics' latest filing, its Net Income stood at -$69.0 million for FY2024, which was down 18.36% from -$58.3 million recorded in FY2023.
  • Janux Therapeutics' 5-year Net Income high stood at -$5.0 million for FY2020, and its period low was -$69.0 million during FY2024.
  • In the last 3 years, Janux Therapeutics' Net Income had a median value of -$63.1 million in 2022 and averaged -$63.4 million.
  • Per our database at Business Quant, Janux Therapeutics' Net Income plummeted by 547.10% in 2021 and then grew by 7.56% in 2023.
  • Yearly analysis of 5 years shows Janux Therapeutics' Net Income stood at -$5.0 million in 2020, then crashed by 547.10% to -$32.7 million in 2021, then plummeted by 93.01% to -$63.1 million in 2022, then rose by 7.56% to -$58.3 million in 2023, then decreased by 18.36% to -$69.0 million in 2024.